Veterinary Medicines

E-SELENSOL 70/1 mg/ml emulsion for injection for cattle, sheep and pigs

Authorised
  • ALPHA-TOCOPHEROL
  • Sodium selenite
Download as PDF

Product identification

Medicine name:
E-SELENSOL 70/1 mg/ml emulsion for injection for cattle, sheep and pigs
E-Selensol, 70/1 mg/ml süsteemulsioon veistele, lammastele ja sigadele
Active substance:
  • ALPHA-TOCOPHEROL
  • Sodium selenite
Target species:
  • Cattle
  • Pig
  • Sheep
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • ALPHA-TOCOPHEROL
    70.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium selenite
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        30
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        30
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CE99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Type II amber coloured glass vials, with bromobutyl rubber stopper and lacquered aluminium cap. Carton box with 1 vial of 50 ml.
  • Type II amber coloured glass vials, with bromobutyl rubber stopper and lacquered aluminium cap. Carton box with 1 vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic (abridged application) - art 13(1)
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2285
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0143/001
Concerned member states:
  • Croatia
  • Cyprus
  • Estonia
  • Greece
  • Latvia
  • Lithuania

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 1/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."